Sr. Medical Director, Cell Therapy, Early Global Development, Oncology R&D
Company: AstraZeneca
Location: Montgomery Village
Posted on: June 26, 2025
|
|
Job Description:
AstraZeneca is a global, science-led, patient-focused
biopharmaceutical company that focuses on the discovery,
development and commercialization of prescription medicines for
some of the world’s most serious diseases. But we’re more than one
of the world’s leading pharmaceutical companies. We have a bold
ambition to provide cures for cancer in every form. We are
following the science to understand cancer and all its complexities
to discover, develop and deliver life-changing treatments and
increase the potential to save the lives of people around the
world. Join the team dedicated to Oncology, with an ambition to
eliminate cancer as a cause of death. It’s our big vision that
unites and inspires us. We are seeking a Medical Director, with a
focus on Cell Therapy, who is a clinician with strong leadership
skills, driven by science and the desire to develop novel therapies
for cancer patients. The Medical Director, Cell Therapy is
accountable of the medical aspects related to cell and gene therapy
trial conduct in multiple tumor indications across multiple
geographies, The ideal candidate will have proficiency in the drug
development process (especially early phase clinical trials),
protocol writing & study conduct, data review and reconciliation,
the principles of translational medicine, and what it takes to lead
teams successfully. This individual will have the opportunity for
growth and development while working in a vibrant environment by:
Providing long-range clinical development planning, planning and
managing of clinical research projects and clinical development
programs in oncology Contribute to and support Department/Clinical
initiatives to improve the quality and content of all clinical
programs as well as the cross functional/organization processes
designed to effectively deliver our R&D portfolio. Serve as
medical monitor with primary responsibility for patient safety and
conduct of assigned trials as well as overall data interpretation
and safety surveillance Establish and approve scientific methods
for design and implementation of applicable clinical protocols,
data collection systems, and final reports Responsible for
assisting in design of clinical development plans and overall
strategy for compounds, therapeutic classes of compounds or
indications in light of developments in the area of clinical and
pharmaceutical oncology Collaborate with pre-clinical and
translational sciences, and senior management in assessing
requirements for emerging products; Provide leadership on
cross-functional product development team(s) as experience allows
Participate in identification, selection and conduct of
negotiations with clinical research centers and investigators;
Participate in the selection and management activities of CROs;
Supervise project team members in planning, conducting and
evaluating clinical trials Lead all aspects of planning and
management of investigator meetings, advisory boards and other
scientific committees. Minimum Qualifications: MD or MBBS degree
and a professional qualification in Oncology and/or Hematology
(Pediatric Onco-hematology allowed) Significant understanding of
the overall drug development and commercialization process 3 years
of experience in clinical research and/or oncology drug development
in pharmaceutical, academic or CRO environment. Conceptual,
analytical, and strategic thinking Ability to influence
strategically and persuade tactfully, to obtain desired outcomes
while maintaining effective, positive, organizational relationships
Preferred Qualifications: MD/PhD in a scientific discipline related
to immunology, oncology and/or gene therapy Experience in molecular
oncology and/or translational science Medical specialty and
subspecialty training and Board Certification Proven leadership
skills and demonstrated ability to interact collaboratively in a
cross-functional environment. The annual base pay (or hourly rate
of compensation) for this position ranges from $265,780.80 to
$398,671.20. Hourly and salaried non-exempt employees will also be
paid overtime pay when working qualifying overtime hours. Base pay
offered may vary depending on multiple individualized factors,
including market location, job-related knowledge, skills, and
experience. In addition, our positions offer a short-term incentive
bonus opportunity; eligibility to participate in our equity-based
long-term incentive program (salaried roles), to receive a
retirement contribution (hourly roles), and commission payment
eligibility (sales roles). Benefits offered included a qualified
retirement program [401(k) plan]; paid vacation and holidays; paid
leaves; and, health benefits including medical, prescription drug,
dental, and vision coverage in accordance with the terms and
conditions of the applicable plans. Additional details of
participation in these benefit plans will be provided if an
employee receives an offer of employment. If hired, employee will
be in an “at-will position” and the Company reserves the right to
modify base pay (as well as any other discretionary payment or
compensation program) at any time, including for reasons related to
individual performance, Company or individual department/team
performance, and market factors.
Keywords: AstraZeneca, Towson , Sr. Medical Director, Cell Therapy, Early Global Development, Oncology R&D, Science, Research & Development , Montgomery Village, Maryland